Literature DB >> 27628589

Statins evidence: when answers also raise questions.

Harlan M Krumholz1.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 27628589     DOI: 10.1136/bmj.i4963

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  8 in total

1.  How Common is Statin Use in the Oldest Old?

Authors:  Wade Thompson; Anton Pottegård; Jesper Bo Nielsen; Peter Haastrup; Dorte Ejg Jarbøl
Journal:  Drugs Aging       Date:  2018-08       Impact factor: 3.923

2.  Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults: The ALLHAT-LLT Randomized Clinical Trial.

Authors:  Benjamin H Han; David Sutin; Jeff D Williamson; Barry R Davis; Linda B Piller; Hannah Pervin; Sara L Pressel; Caroline S Blaum
Journal:  JAMA Intern Med       Date:  2017-07-01       Impact factor: 21.873

3.  Statins for primary prevention of cardiovascular disease: modelling guidelines and patient preferences based on an Irish cohort.

Authors:  Paula Byrne; John Cullinan; Paddy Gillespie; Rafael Perera; Susan M Smith
Journal:  Br J Gen Pract       Date:  2019-04-23       Impact factor: 5.386

4.  Survival Benefits of Statins for Primary Prevention: A Cohort Study.

Authors:  Lisanne A Gitsels; Elena Kulinskaya; Nicholas Steel
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

Review 5.  Statins for the primary prevention of cardiovascular disease: an overview of systematic reviews.

Authors:  Paula Byrne; John Cullinan; Amelia Smith; Susan M Smith
Journal:  BMJ Open       Date:  2019-04-23       Impact factor: 2.692

6.  Long-Term Effectiveness and Safety of Initiating Statin Therapy After Index Revascularization In Patients With Peripheral Arterial Occlusive Disease.

Authors:  Frederik Peters; Jenny Kuchenbecker; Thea Kreutzburg; Ursula Marschall; E Sebastian Debus; Christian-Alexander Behrendt
Journal:  J Am Heart Assoc       Date:  2020-11-13       Impact factor: 5.501

7.  Prevalence and factors associated with lipid-lowering medications use for primary and secondary prevention of cardiovascular diseases among Malaysians: the REDISCOVER study.

Authors:  Noorhida Baharudin; Mohamed-Syarif Mohamed-Yassin; Aqil Mohammad Daher; Anis Safura Ramli; Nor-Ashikin Mohamed Noor Khan; Suraya Abdul-Razak
Journal:  BMC Public Health       Date:  2022-02-04       Impact factor: 3.295

8.  Residual cardiovascular risk in individuals on lipid-lowering treatment: quantifying absolute and relative risk in the community.

Authors:  Wolfgang Lieb; Danielle M Enserro; Martin G Larson; Ramachandran S Vasan
Journal:  Open Heart       Date:  2018-01-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.